Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 2, 2007, Pages 279-282

  Chaiwongkot, Arkom ^a   Pientong, Chamsai ^a   Ekalaksananan, Tipaya ^a   Kongyingyoes, Bunkerd ^a   Thinkhamrop, Jadsada ^b   Yuenyao, Pissamai ^b   Sriamporn, Supannee ^a  

^a Department of Mathematics   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Abnormal cervical cells; HPV DNA screening; PCR performance; Primer sets

Indexed keywords

PRIMER DNA; VIRUS DNA;

ALPHAPAPILLOMAVIRUS; ARTICLE; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MASS SCREENING; PATHOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CERVIX UTERI; DNA PRIMERS; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 40449116441     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bauer HM, Greer CE, Manos MM (1992). Detection of genital human papillomavirus infection using PCR. In: Herrington, C. S. and McGee, J. O. D. (Eds.). 'Diagnostic Molecular Pathology: a Practical Approach'. Oxford: Oxford University Press, 131-52.
2. Cuzick J, Clavel C, Petry KU, et al (2006). Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer, 119, 1095-101.
3. Fahey MT, Irwig L, Macaskill P (1995). Meta-analysis of Pap test accuracy. Am J Epidemiol, 141, 680-9.
4. Gallo G, Bibbo M, Bagella L, et al (2003). Study of viral integration of HPV-16 in young patients with LSIL. J Clin Pathol, 56, 532-6.
5. Hubbard RA (2003). Human papillomavirus testing methods. Arch Pathol Lab Med, 127, 940-5.
6. Kulasingam SL, Hughes JP, Kiviat NB, et al (2002). Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA, 288, 1749-57.
7. Lillo FB, Lodini S, Ferrari D, et al (2005). Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis, 40, 451-7.
8. Monnier-Benoit S, Dalstein V, Riethmuller D, et al (2006). Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol, 35, 270-7.
9. Nanda K, McCrory DC, Myers ER, et al (2000). Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med, 132, 810-9.
10. Qu W, Jiang G, Cruz Y, et al (1997). PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol, 35, 1304-10.
11. Remmerbach TW, Brinckmann UG, Hemprich A, et al (2004). PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol, 30, 302-8.
12. Snijders PJ, van den Brule AJ, Meijer CJ (2003). The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol, 201, 1-6.
13. Solomon D, Schiffman M, Tarone R (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst, 93, 293-9.
14. Sun CA, Lai HC, Chang CC, et al (2001). The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol, 83, 95-9.
15. Swan DC, Tucker RA, Tortolero-Luna G, et al (1999). Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol, 37, 1030-4.
16. van Duin M, Snijders PJ, Schrijnemakers HF, et al (2002). Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer, 98, 590-5.
17. Walboomers J, Jacobs M, Manos M, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
18. Weissenborn SJ, Funke AM, Hellmich M, et al (2003). Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol, 41, 2763-7.
19. Wu Y, Chen Y, Li L, et al (2006). Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 35, 264-9.
20. Ylitalo N, Sorensen P, Josefsson AM, et al (2000). Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet, 355, 2194-8.